SPY330.65-3.85 -1.15%
DIA276.52-2.38 -0.85%
IXIC10,793.28-117.00 -1.07%

Citigroup Maintains Buy on Surgery Partners, Raises Price Target to $15

Citigroup maintains Surgery Partners (NASDAQ:SGRY) with a Buy and raises the price target from $10 to $15.

Benzinga · 05/13/2020 14:34

Citigroup maintains Surgery Partners (NASDAQ:SGRY) with a Buy and raises the price target from $10 to $15.